DPG Mitgliedschaft

This block is broken or missing. You may be missing content or you might need to enable the original module.

Keyword: Gilead


Gilead Takes Immunomedics for $21 Billion

16.09.2020 -

Gilead Sciences is to acquire Immunomedics for approximately $21 billion. The deal, unanimously approved by both companies' boards of directors, will be funded by $15...


FDA Extends EUA for Remdesivir in Covid Patients

02.09.2020 -

The US Food and Drug Administration (FDA) has come under fire again as the federal health agency issued its third Emergency Use Authorization (EUA) for a Covid-19...


Pfizer Teams up with Gilead to Make Remdesivir

11.08.2020 -

After teaming up with Germany’s BioNTech to develop a vaccine for Covid-19, US drugs giant Pfizer is joining US Gilead Sciences on the therapeutic side. The biopharma...


EU Inks Remdesivir Supply Deal with Gilead

30.07.2020 -

The European Commission has signed a €63 million contract with Gilead Sciences to deliver batches of Veklury, Gilead’s name for the antiviral remdesivir, to the EU’s 27...


EU Talks to Gilead About Remdesivir Supply

09.07.2020 -

After it emerged last week that the US federal government had nailed down the lion’s share of the world’s supply of the antiviral remdesivir, Gilead Sciences’ new drug...


US Nabs Bulk of World Remdesivir Supply

03.07.2020 -

As the global coronavirus pandemic shows no signs of abating, the US “America first” approach to preventing and treating Covid-19 has again provoked worldwide concern.


Dr. Reddy's Enters into a Licensing Agreement with Gilead for Remdesivir

15.06.2020 - Dr. Reddy's Laboratories has entered into a non-exclusive licensing agreement with Gilead Sciences. The agreement will grant Dr. Reddy’s the right to register, manufacture and sell...


AstraZeneca Said Weighing Gilead Merger

09.06.2020 - Anglo-Swedish drugmaker AstraZeneca is weighing a merger with US biotech Gilead Sciences, the Bloomberg news agency has reported. Surpassing Bristol Myers Squibb’s $74 billion...

Ehrenamtliches Engagement

This block is broken or missing. You may be missing content or you might need to enable the original module.